Form 4 Filing: Lebowitz Peter F Acquires (Grant) shares of $BBOT

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

BridgeBio Oncology Therapeutics, Inc.

Ticker: $BBOT

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-16

Shares: 7,289

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lebowitz Peter F, holds the title of Director at BridgeBio Oncology Therapeutics, Inc..

On 2026-06-16, the insider transacted 7,289 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Lebowitz Peter F (Director) was granted $0 of $BBOT

Post-Transaction Position: 7,289 shares

SEC Accession No: 0001193125-26-276046 (CIK: 2121402)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$BBOT Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$BBOT News Coverage